# Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions

> **NCT03106051** · — · COMPLETED · sponsor: **Amgen** · enrollment: 526 (actual)

## Conditions studied

- Arthritis, Psoriatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03106051
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-18
- **Primary completion:** 2018-07-31
- **Final completion:** 2020-08-12
- **Target enrollment:** 526 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03106051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03106051, "Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03106051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*